Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
32 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Aboleris Holdco from Charleroi, company number BE0803217012, closed financial year 2025 with a result of € -5.8 million after tax. For that financial year Aboleris Holdco recorded a gross margin of € -5.8 million and equity of € 14.3 million. Compared with financial year 2024, the result moved from € -7.8 million to € -5.8 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 14.3 million
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5.8 million
▲ 25 % less loss than in 2024
Profit after tax over the fiscal year.
€ 888,423
▼ 73% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -16.7 million.
People and assets in 2025
€ 3,637
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 509,754
▼ 24% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -3,173,529 | € -7,805,092 | € -5,812,529 | ▲ € 2 million |
| Profit after taxes | € -3,106,570 | € -7,782,711 | € -5,806,774 | ▲ € 2 million |
| Equity | € 12,482,907 | € 12,600,196 | € 14,292,930 | ▲ 13% |
| Total debts | € 619,645 | € 667,120 | € 509,754 | ▼ 24% |
| Cash | € 1,801,378 | € 3,263,270 | € 888,423 | ▼ 73% |
| Retained profit | € -3,106,570 | € -10,889,281 | € -16,696,055 | ▼ € 5.8 million |
| Balance sheet total | € 13,102,552 | € 13,267,316 | € 14,802,684 | ▲ 12% |
Key figures of Aboleris Holdco, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Aboleris Holdco?
What happened at Aboleris Holdco in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Criteria Bio Ventures SICC SA stepped down as director. NBB
- Biotech Corporate dev stepped down as director. NBB
- Sound Bioventures Management AB stepped down as director. NBB
- Newton Biocapital Partners SRL stepped down as director. NBB
- SPARAXIS SA stepped down as director. NBB
- A.L.M. Management & Consulting SPRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 5.8 million. Source: NBB ↗
- Newton Biocapital Partners SRL became a director. NBB
In short
From € 3.1 million loss in 2023 to € 5.8 million loss in 2025.
Paid € 7,806 in corporate taxes since 2023.
Management
The stake of Newton Biocapital I, pricaf privée de droit belge, SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, INVESTSUD TECH comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Aboleris HoldcoThe shares are held by Newton Biocapital I, pricaf privée de droit belge (25.7%), SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (14%) and INVESTSUD TECH (2.1%). It owns 100% of Aboleris Pharma itself.
Directors
According to the 2025 annual accounts
Director · represented by Pablo CIRONI LOPEZ
since 2024 · until 2030
Newton Biocapital Partners SRL
Director · represented by Alain PARTHOENS
Also active at: SYNERGIA MEDICAL, Newton Biocapital I, pricaf privée de droit belge, Newton Biocapital I Investment Pool, EPICS THERAPEUTICS, DeuterOncology, NEUVASQ BIOTECHNOLOGIES, FLANDERSBIO
since 2025 · until 2029
Director · represented by Caroline THIELEN
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International, Ateliers Pierre Cerfontaine, Floridienne, Fonderies J. Marichal Ketin et Cie, JUNGLING, MEBF +224 more
since 2023 · until 2029
Director · represented by Frédéric LEGROS
since 2024 · until 2030
Sound Bioventures Management AB
Director · represented by Casper BREUM
since 2025 · until 2030
A.L.M. Management & Consulting SPRL
Director · represented by Ann MEULEMANS
Also active at: 2 BRIDGE, Healis Holding
since 2023 · until 2029
Shareholders
Participations
Aboleris Pharma
100%
Establishments
Establishment units
Physical locations of this company
Rue Antoine de Saint-Exupéry 14
6041 Charleroi
Rue Auguste Piccard 48
6041 Charleroi
Active since 27 June 2023
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 32 companies are registered at this address.
All companies at this address →ASSOCIATION VINCOTTE NUCLEAR
€ -422,124 gross margin · 2025
REAL FUNDS DEVELOPMENTS
€ -16,241 gross margin · 2026
ENTREPRISE, FINANCEMENT & DEVELOPPEMENT
€ -8,142 gross margin · 2025
EIFFAGE REAL ESTATE WALLONIE
€ 41,491 revenue · 2025
IMELCO
€ 324,245 gross margin · 2025
+27 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
IONOS-AS This is the joint network for IONOS, Fasthosts, Arsys, 1&1 Mail and Media and 1&1 Telecom. Formerly known as 1&1 Internet SE., DE
Domain
Domain
aboleris-pharma.com
Registered
2018-03-24
Registrar
IONOS SE
Expires
2026-03-24
Website info
Features
Security
Network
Details
- Company number
- 0803.217.012
- VAT number
- BE 0803.217.012
- Registered office
- Rue Antoine de Saint-Exupéry 14, 6041 Charleroi
- Names & denominations
- Aboleris Holdco
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 June 2023
- Peppol
- Active · Active since 6 Mar 2026
- Contact
- aboleris-pharma.com [email protected]
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van hoofdkantoren
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied